The genetics of ivermectin resistance in Caenorhabditis elegans
AUTOR(ES)
Dent, Joseph A.
FONTE
The National Academy of Sciences
RESUMO
The ability of organisms to evolve resistance threatens the effectiveness of every antibiotic drug. We show that in the nematode Caenorhabditis elegans, simultaneous mutation of three genes, avr-14, avr-15, and glc-1, encoding glutamate-gated chloride channel (GluCl) α-type subunits confers high-level resistance to the antiparasitic drug ivermectin. In contrast, mutating any two channel genes confers modest or no resistance. We propose a model in which ivermectin sensitivity in C. elegans is mediated by genes affecting parallel genetic pathways defined by the family of GluCl genes. The sensitivity of these pathways is further modulated by unc-7, unc-9, and the Dyf (dye filling defective) genes, which alter the structure of the nervous system. Our results suggest that the evolution of drug resistance can be slowed by targeting antibiotic drugs to several members of a multigene family.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15988Documentos Relacionados
- Differences in protein expression associated with ivermectin resistance in Caenorhabditis elegans
- The Genetics of Levamisole Resistance in the Nematode CAENORHABDITIS ELEGANS
- The Genetics of CAENORHABDITIS ELEGANS
- The Genetics of Feeding in Caenorhabditis Elegans
- The genetics of caloric restriction in Caenorhabditis elegans
